
HealthcareNew Jersey2 open jobs
Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg (U.S.), bevacizumab gamma (E.U.)). LYTENAVA™ is the first ophthalmic formulation of bevacizumab to receive U.S. FDA approval and European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany, Austria, and the UK as a treatment for wet AMD.
Get matched to jobsYes. We confirmed Outlook Therapeutics, Inc. is a real employer and traced every listing to an original posting before publishing.
Outlook Therapeutics, Inc. currently has 2 verified open jobs on JobAssist, with 1 added in the last 30 days.
Yes – upload your resume and JobAssist tailors and submits applications to matching Outlook Therapeutics, Inc. roles for your approval.
Outlook Therapeutics, Inc. lists a mix of hybrid and remote positions – each listing shows its workplace type up front.